Finland – Medical imaging services – Magneettikuvantamispalvelut
ted.europa.eu
Buyer: Helsingin ja Uudenmaan Sairaanhoitopiirin kuntayhtymä | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-...
TenderProcurement ContractFinlandOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 1, 2027
Buyer: Helsingin ja Uudenmaan Sairaanhoitopiirin kuntayhtymä | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-01
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Guanfacin, ATC N06BA21
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Relugolix, ATC L02BX04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pazopanib, ATC L01EX03
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fluorouracil, ATC D11AF05
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aflibercept, ausgenommen 114,3 mg/ml, ATC S01LA05
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Testosteron in der Darreichungsform Injektionslösung, ATC G03BA03
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Beclometason dipropionat, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/4,91µg, ATC R03AK08
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ranibizumab in der Darreichungsform Injektionslösung in der Fertigspritze, ATC S01LA04
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
Lithuania – Software programming and consultancy services – QGIS vystymo paslaugos, siekiant sukurti dinaminę pirkimo sistemą
ted.europa.eu
Buyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-04
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 4, 2027
Buyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-04
TEN
Lithuania – Software programming and consultancy services – QGIS vystymo paslaugos, siekiant sukurti dinaminę pirkimo sistemą
ted.europa.eu
Buyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-04
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 4, 2027
Buyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-04
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. IHP, INH), ATC R03AK08 für die Zeit 01.01.2026 - 31.12.2027
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04 und A10AD04 für die Zeit 01.01.2026 - 31.12.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Buserelin, ATC L02AE01 für die Zeit 01.01.2026 - 31.12.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13 für die Zeit 01.01.2026 - 31.12.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.01.2026 - 31.12.2027
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
grants.gov
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) developmen...
GrantMixedUnited StatesOpen
AmountAward ceiling: $1,500,000
DeadlineNov 5, 2027
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; development of biomarkers for target engagement; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing. Applications not responsive to this NOFO include research on basic mechanisms of disease or mechanisms of drug action; development ofrisk, diagnostic, prognostic, predictive, and preventionbiomarkers, devices, non-pharmacological i...
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
39476
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.01.2026 zu diversen Wirkstoffen im Rahmen eines Open-House-VerfahrensBuyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-01
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: BARMER Beschaffung und Vergabe | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-01
39478
Bulgaria – Medical consumables – ДИНАМИЧНА СИСТЕМА ЗА ПОКУПКИ (ДСП) ЗА ДОСТАВКА НА МЕДИЦИНСКИ ИЗДЕЛИЯ ЗА НУЖДИТЕ НА ЦСМП-ВАРНАBuyer: ЦЕНТЪР ЗА СПЕШНА МЕДИЦИНСКА ПОМОЩ - ВАРНА | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadlin...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
Finland – Medical imaging services – MagneettikuvantamispalvelutBuyer: Helsingin ja Uudenmaan Sairaanhoitopiirin kuntayhtymä | Notice type: cn-standard | Procedure: restricted | Contract: servic...
Tender
Procurement Contract
Finland
Not provided on the source page. Please check the official source.
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
39488
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ranibizumab in der Darreichungsform Injektionslösung in der Fertigspritze, ATC S01LA04Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-03
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Lithuania – Software programming and consultancy services – QGIS vystymo paslaugos, siekiant sukurti dinaminę pirkimo sistemąBuyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadlin...
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
Buyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-11-04
39492
Lithuania – Software programming and consultancy services – QGIS vystymo paslaugos, siekiant sukurti dinaminę pirkimo sistemąBuyer: Valstybės įmonė Valstybinių miškų urėdija | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadlin...
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-05
39495
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Insulin lispro, ATC A10AB04 und A10AD04 für die Zeit 01.01.2026 - 31.12.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-11-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical...
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; development of biomarkers for target engagement; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing. Applications not responsive to this NOFO include research on basic mechanisms of disease or mechanisms of drug action; development ofrisk, diagnostic, prognostic, predictive, and preventionbiomarkers, devices, non-pharmacological interventions (e.g., exercise, diet, cognitive training), repurposed drugs and combination therapies; discovery activities such as high-throughput screening and hit optimization; and stand-alone clinical trials.
No saved opportunities on this page. Use the star icon near an opportunity title.
